Technology Platforms for Products Under Development
Self-Assembled Nanoparticles for Improved Chemotherapy
Self-Assembled Biocompatible Polymeric Nanoparticles Containing Doxorubicin (DOX)
Prolonged circulation time for enhanced tumor delivery
Improved Solid Tumor Delivery with Reduced Chemotoxicity
Fluorescent-labeled nanoparticles gradually accumulated in tumor tissues (A) Tissue distribution at 24h post i.v. administration of nanoparticles exhibited significant tumor accumulation.
Biomacromolecules. 2014, 15 (11): 4363–4375
Anti-Tumor Efficacy and Reduced Organ Toxicity
Efficacy is comparable to free Dox
Toxicity is greatly reduced